Nkgen Biotech, Inc.
NKGN
Revenue
0.00
▼-3.00k▼-100.00%
12 Months ChangeAssets
15.65M
▼-668.00k▼-4.09%
3 Months ChangeLiabilities
85.37M
▲13.99M▲19.61%
3 Months ChangeFree Cash Flow
-21.95M
▲710.00k▲3.13%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001213900-24-092361
2024-10-24
Form 8-K
ID: 0001213900-24-090370
2024-10-10
Form 8-K
ID: 0001213900-24-086716
2024-10-04
Form 8-K
ID: 0001213900-24-085185
2024-10-03
Form 8-K
ID: 0001213900-24-085116
2024-09-27
Form 8-K
ID: 0001213900-24-082695
2024-09-20
Form 8-K
ID: 0001213900-24-080690
2024-09-17
Form 8-K
ID: 0001213900-24-079142
2024-09-16
Form 8-K
ID: 0001213900-24-078986
2024-09-12
Form 10-Q
ID: 0001628280-24-040255